Skip to main content

Anthony Daniels Archives

The Alliance for Eye and Vision Research honors two from VEI

Sep. 8, 2016—Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR).

Read more


Two receive Research to Prevent Blindness grants

Jul. 21, 2016—Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.

Read more


Gifts highlight strong, lasting bonds between patients and healers

Mar. 24, 2016—Sometimes saying thank you just isn’t enough.

Read more


Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

Read more


Novel therapy eases stress of retinoblastoma treatment

Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

Read more


Upcoming Events

MORE EVENTS »